Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2899-2911

Bentham Science Publishers

Access to resources Recommend Favorite

Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers

By  

Current Drug Targets, Vol. 12, Iss. 14, 2011-12 ,pp. : 2016-2033

Bentham Science Publishers

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of agents targeting the type I insulin-like growth factor receptor

By Zhang Hua   Yee Douglas  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 12, 2004-12 ,pp. : 1569-1577

Informa Healthcare

Access to resources Recommend Favorite

The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite